86 related articles for article (PubMed ID: 6119269)
1. Interactions between methyl xanthines and beta adrenergic agonists.
FDA Drug Bull; 1981 Nov; 11(3):19-20. PubMed ID: 6119269
[No Abstract] [Full Text] [Related]
2. Combined use of beta-adrenergic agonists and methyl xanthines.
Nicklas RA; Whitehurst VE; Donohoe RF
N Engl J Med; 1982 Aug; 307(9):557-8. PubMed ID: 6124888
[No Abstract] [Full Text] [Related]
3. More on combined beta-agonists and methylxanthines in asthma.
Lehr D; Guideri G
N Engl J Med; 1983 Dec; 309(25):1581-2. PubMed ID: 6140640
[No Abstract] [Full Text] [Related]
4. Interactions of quazodine with cardiotoxic doses of ouabain in the anesthetized dog.
Gomoll AW; Byrne JE; McKinney GR
Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):16-27. PubMed ID: 4151046
[No Abstract] [Full Text] [Related]
5. Orthogonal analysis of aggravating effects of alpha-, beta-agonists and leukocytes on reperfusion-induced arrhythmias and ventricular fibrillation in Langendorff's rat heart.
Dai DZ; An LF; Huang DY; Sun RY
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):145-8. PubMed ID: 9772665
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic stimulants and asthma mortality.
Svedmyr N
Scand J Respir Dis Suppl; 1977; 101():85-9. PubMed ID: 24269
[No Abstract] [Full Text] [Related]
7. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
[TBL] [Abstract][Full Text] [Related]
8. Halothane-induced cardiac arrhythmias following administration of aminophylline in experimental animals.
Stirt JA; Berger JM; Roe SD; Ricker SM; Sullivan SF
Anesth Analg; 1981 Jul; 60(7):517-20. PubMed ID: 7195667
[TBL] [Abstract][Full Text] [Related]
9. Combined methylxanthines and beta-adrenergic agonists in the treatment of severe asthma.
Morell F; Orriols R; de Gracia J; Laporte JR
Drug Intell Clin Pharm; 1983 Nov; 17(11):820-1. PubMed ID: 6139270
[No Abstract] [Full Text] [Related]
10. [New developments in predicting the arrhythmogenic effect of beta-adrenomimetics in chronic obstructive lung diseases].
Andrianov VP; Boĭtsov SA; Kuchmin AN; Tishchenko OL; Nedoshivin KIu
Voen Med Zh; 1996 Nov; 317(11):34-6. PubMed ID: 9036628
[No Abstract] [Full Text] [Related]
11. Lack of arrhythmogenicity of isoflurane following administration of aminophylline in dogs.
Stirt JA; Berger JM; Sullivan SF
Anesth Analg; 1983 Jun; 62(6):568-71. PubMed ID: 6846878
[TBL] [Abstract][Full Text] [Related]
12. Anaesthetic arrhythmias: is there rational therapy?
Opie LH
S Afr Med J; 1981 Mar; 59(12):417-8. PubMed ID: 6111130
[TBL] [Abstract][Full Text] [Related]
13. The beta-agonist saga.
Nicholas SS
Am J Respir Crit Care Med; 2010 Jan; 181(2):194. PubMed ID: 20053970
[No Abstract] [Full Text] [Related]
14. Cardiac arrhythmias caused by nebulised beta-agonist therapy.
Higgins RM; Cookson WO; Lane DJ; John SM; McCarthy GL; McCarthy ST
Lancet; 1987 Oct; 2(8563):863-4. PubMed ID: 2889068
[No Abstract] [Full Text] [Related]
15. Cardiac arrest during dobutamine stress echocardiography.
Salustri A; Biferali F; Palamara A
G Ital Cardiol; 1997 Jan; 27(1):69-71. PubMed ID: 9199944
[TBL] [Abstract][Full Text] [Related]
16. Thermoregulatory effects of beta adrenoceptors: effects of selective agonists and the interaction of antagonists with isoproterenol and BRL-35135 in the cold.
Carlisle HJ; Stock MJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1446-53. PubMed ID: 8103795
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive agents: adrenergic beta receptor agonists].
Thien T; Man in't Veld AJ; Lenders JW
Ned Tijdschr Geneeskd; 1989 Mar; 133(10):484-9. PubMed ID: 2565536
[No Abstract] [Full Text] [Related]
18. Safety of enflurane following administration of aminophylline in experimental animals.
Stirt JA; Berger JM; Roe SD; Ricker SM; Sullivan SF
Anesth Analg; 1981 Dec; 60(12):871-3. PubMed ID: 7198395
[TBL] [Abstract][Full Text] [Related]
19. Treatment of vascular smooth muscle cells with estradiol and beta-adrenergic agonists has an additive effect on cAMP levels, but no additive effect on inhibition of collagen synthesis.
Dimopoulos GJ; Langner RO
J Pharm Pharmacol; 2005 Aug; 57(8):1005-10. PubMed ID: 16102256
[TBL] [Abstract][Full Text] [Related]
20. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
Pittman RN; Molinoff PB
Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
